Devices › Device types
FDA product code NEK · class 3 · Unknown
Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction: medical device reports filed with FDA
13,040 reports carry this product code, 2003–2026; 3 brands with a page.
- 13,040
- reports with this product code
- 0.1% of all MAUDE reports
- 43
- reports, 12 months to August 2026
- 53 in the 12 months before
- 0.7%
- classified as malfunction
- 62.3% across all reports
- 0.3%
- classified as death, as reported
- 0.9% across all reports
Product code NEK is FDA's classification for "Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction" (unknown panel), a class 3 device. 13,040 medical device reports carry this product code, 0.1% of the MAUDE database, from March 2003 to July 2026.
43 reports arrived in the 12 months to August 2026, down 19% from 53 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.5%), malfunction (0.7%) and death (0.3%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Infuse Bone Graft | 11,989 | 36 | 0.3% | 0.4% |
| Medtronic Infuse Bone Graft Or Rhbmp2 | 477 | 0 | 0% | 0% |
| Verte-Stack Spinal System | 5 | 0 | 0.5% | 63.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medtronic Sofamor Danek USA | 12,001 | 92% |
| Medtronic | 555 | 4.3% |
| Medtronic Sofamor Danek | 261 | 2% |
| Warsaw Orthopedics | 5 | 0% |
| Warsaw Orthopedic | 3 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 1,004 | 7.7% |
| Device remains implanted | 118 | 0.9% |
| Device operates differently than expectedthe device behaved unexpectedly | 91 | 0.7% |
| Off-label use | 81 | 0.6% |
| Explanted | 58 | 0.4% |
| Migration or expulsion of device | 49 | 0.4% |
| Patient-device incompatibilitythe device did not suit the patient | 38 | 0.3% |
| Breakthe device broke | 23 | 0.2% |
| Osseointegration problem | 23 | 0.2% |
| Replace | 21 | 0.2% |
| Improper or incorrect procedure or method | 19 | 0.1% |
| Other (for use when an appropriate device code cannot be identified) | 11 | 0.1% |
| Failure to osseointegrate | 9 | 0.1% |
| Malposition of device | 9 | 0.1% |
| Device slipped | 8 | 0.1% |
| Nonstandard device | 8 | 0.1% |
| Loss of osseointegration | 6 | 0% |
| Collapse | 5 | 0% |
| Device dislodged or dislocated | 4 | 0% |
| Implant, removal of | 4 | 0% |
Questions about filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction reports
What is product code NEK?
FDA's classification code for "Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
13,040 reports through August 2026, 43 of them in the latest 12 months.
Which brands appear most often?
Infuse Bone Graft (11,989), Medtronic Infuse Bone Graft Or Rhbmp2 (477) and Verte-Stack Spinal System (5). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.